Association between polygenic risk scores for hypertension and low-density lipoprotein cholesterol with incident

Dong Hoon Kang1,2, Hyung Woo Kim1,3, Byoungwhi Ko1

  • 1Department of Internal Medicine and Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Republic of Korea.

Insights

Genetic risk for hypertension (HTN) significantly increases chronic kidney disease (CKD) risk, while high LDL-C genetic risk does not. Combined genetic predispositions for HTN and high LDL-C do not synergistically elevate CKD risk.

Area of Science:

  • Genetics
  • Nephrology
  • Cardiovascular Disease

Background:

  • The clinical significance of genetic predisposition to hypertension (HTN) and high low-density lipoprotein cholesterol (LDL-C) for incident chronic kidney disease (CKD) remains unclear.
  • Investigating polygenic risk scores (PRSs) can elucidate these genetic associations.

Purpose of the Study:

  • To evaluate the predictive capability of PRSs for HTN and high LDL-C in the development of incident CKD.
  • To determine the independent and combined effects of genetic risk factors on CKD onset.

Main Methods:

  • Utilized UK Biobank data from 245,893 participants (2006-2022).
  • Assessed incident CKD using cause-specific competing-risk models.
  • Employed PRSs for HTN (PRS HTN) and high LDL-C (PRS LDL-C) as primary exposures.

Main Results:

  • A 1-SD increase in PRS HTN was linked to a 7% higher risk of incident CKD (HR, 1.07; 95% CI, 1.05-1.10).
  • PRS LDL-C showed no significant association with incident CKD.
  • Individuals in the high HTN genetic risk group exhibited a 13% increased CKD risk (HR, 1.13; 95% CI, 1.06-1.20).

Conclusions:

  • Higher genetic predisposition to HTN is associated with an increased risk of developing CKD.
  • Genetic risk for high LDL-C does not significantly predict CKD development.
  • Combined genetic predispositions for HTN and high LDL-C do not show synergistic effects on CKD risk.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
58
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K